Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06609928. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07198867. IPD Sharing: NO. Countries: 1. Publications: 0.
Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02809092. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Venetoclax Combined With Azacitidine and CAG in Refractory/Relapse Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05807347. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05345938. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06382168. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
ClinicalTrials.gov study NCT04905810. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01567059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1)
ClinicalTrials.gov study NCT01146977. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03190278. IPD Sharing: NO. Countries: 1. Publications: 0.
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06459024. IPD Sharing: NO. Countries: 6. Publications: 0.
VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01541280. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00795548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07144020. IPD Sharing: NO. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00017472. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy
ClinicalTrials.gov study NCT03499912. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition
ClinicalTrials.gov study NCT03284593. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01126814. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Incidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive Therapy
ClinicalTrials.gov study NCT03450512. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04946890. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.